Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rosuvastatin Calcium Dispersible Tablets

Approval Number

国药准字H20237159

Company浙江京新药业股份有限公司

Registration Date

April 27, 2024

Previous Approval Numbers

国药准字H20193125

Drug Information

Generic Name

瑞舒伐他汀钙分散片

Dosage Form

片剂

Strength

5mg（按C₂₂H₂₈FN₃O₆S计）

Drug Type

化学药品

Registration Date

April 27, 2024

Company Information

Applicant Company

Company Name浙江京新药业股份有限公司

Company Address

浙江省新昌县羽林街道新昌大道东路800号

Manufacturing Company

Company Name浙江京新药业股份有限公司

Company Address

浙江省新昌县羽林街道新昌大道东路800号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy